- Report
- May 2024
- 100 Pages
Global
From €3809EUR$3,995USD£3,246GBP
- Report
- June 2024
- 449 Pages
Global
From €6669EUR$6,995USD£5,684GBP
- Report
- March 2024
- 192 Pages
Global
From €3217EUR$3,374USD£2,742GBP
€3574EUR$3,749USD£3,046GBP
- Report
- March 2024
- 188 Pages
Global
From €3217EUR$3,374USD£2,742GBP
€3574EUR$3,749USD£3,046GBP
- Report
- March 2024
- 195 Pages
Global
From €3217EUR$3,374USD£2,742GBP
€3574EUR$3,749USD£3,046GBP
- Report
- January 2024
- 269 Pages
Global
From €6655EUR$7,225USD£5,481GBP
- Report
- December 2023
- 145 Pages
Global
From €5672EUR$5,950USD£4,835GBP
- Report
- September 2023
- 120 Pages
Global
From €5672EUR$5,950USD£4,835GBP
- Report
- February 2024
- 175 Pages
Global
From €4767EUR$5,000USD£4,063GBP
- Report
- February 2024
- 175 Pages
Global
From €4767EUR$5,000USD£4,063GBP
- Report
- January 2024
- 175 Pages
Global
From €4767EUR$5,000USD£4,063GBP
- Report
- November 2023
- 150 Pages
Global
From €4624EUR$4,850USD£3,941GBP
- Report
- March 2024
- 146 Pages
Global
From €2859EUR$2,999USD£2,437GBP
- Report
- November 2023
- 149 Pages
Global
From €2382EUR$2,499USD£2,031GBP
- Report
- June 2024
- 244 Pages
Global
From €5196EUR$5,450USD£4,429GBP
- Report
- June 2024
- 266 Pages
Global
From €5196EUR$5,450USD£4,429GBP
- Report
- February 2024
- 150 Pages
Global
From €4528EUR$4,750USD£3,860GBP
- Drug Pipelines
- January 2024
- 90 Pages
Global
From €1430EUR$1,500USD£1,219GBP
- Report
- November 2023
- 30 Pages
Global
From €2622EUR$2,750USD£2,235GBP
- Report
- July 2023
- 118 Pages
Global
From €4290EUR$4,500USD£3,657GBP
The Macrolide Antibiotic market is a segment of the Infectious Diseases Drugs market. Macrolides are a class of antibiotics used to treat a wide range of bacterial infections, including respiratory tract infections, skin infections, and sexually transmitted diseases. Macrolides are generally well-tolerated and have fewer side effects than other antibiotics. They are also effective against drug-resistant bacteria, making them an important tool in the fight against antibiotic resistance. Macrolides are available in both oral and intravenous formulations, and are often used in combination with other antibiotics.
The Macrolide Antibiotic market is highly competitive, with a number of large pharmaceutical companies offering products. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, and Novartis. Show Less Read more